Jean-François Toussaint, Sanofi's global head of vaccines R&D, speaking at a conference at the company's site in Lyon last ...

The FDA has approved a new at-home test for common sexually transmitted infections and diseases. The test for chlamydia, ...

The U.S. Food and Drug Administration granted marketing authorization for the first home-based, nonprescription diagnostic ...

Paris: Sanofi has received the US Food and Drug Administration (USFDA) fast-track designation for its mRNA vaccine candidate ...

As part of the Fast Track designation, Sanofi is set to launch a Phase I/II trial to evaluate the immunogenicity and safety ...

The FDA has approved the first at-home, nonprescription test for chlamydia, gonorrhea, and trichomoniasis in women. The Visby ...

This decision underscores the need for a preventative measure against the chlamydia, which affects millions worldwide.

The US Food and Drug Administration (FDA) has granted marketing authorization for the first at-home test to diagnose ...